A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

NCT01625897 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: MP-214
DRUG: Risperidone

Sponsor

Tanabe Pharma Corporation